| Literature DB >> 27508091 |
Alberto Izzotti1, Stefano Carozzo2, Alessandra Pulliero2, Dinara Zhabayeva3, Jean Louis Ravetti4, Rakhmet Bersimbaev3.
Abstract
One of the goals of contemporary cancer research is the development of new markers that facilitate earlier and non-invasive diagnosis. MicroRNAs are non-coding RNA molecules that regulate gene expression; studies have shown that their expression levels are altered in cancer. Recently, extra-cellular microRNAs have been detected in biological fluids and studied as possible cancer markers that can be detected by noninvasive procedures. In this review, we analyze the current understanding of extracellular miRNAs based on clinical studies to establish their possible use for the prevention of the most common tumors. Despite discrepancies among different studies of the same cancers, panels of specific extracellular microRNAs are emerging as a new tool for the secondary (selection of high-risk individuals to undergo screening) and tertiary (relapse) prevention of cancer.Entities:
Keywords: Biomarker; cancer; diagnosis; exsosome; miRNA; microvescicle; outcome; prevention; prognosis; therapy
Year: 2016 PMID: 27508091 PMCID: PMC4969398
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 6.166